Welcome to our dedicated page for Aquabounty Technologies news (Ticker: AQB), a resource for investors and traders seeking the latest updates and insights on Aquabounty Technologies stock.
AquaBounty Technologies Inc. (AQB) pioneers sustainable aquaculture through land-based farming systems and genetic innovation. This dedicated news hub provides investors and industry stakeholders with essential updates on operational milestones, financial developments, and technological advancements in antibiotic-free salmon production.
Access timely reports on earnings announcements, regulatory updates, and strategic partnerships that shape AQB's position in the biotechnology-driven aquaculture sector. Our curated collection features press releases about production facility expansions, genetic research breakthroughs, and sustainability initiatives aligned with global food security goals.
Key updates include progress in recirculating aquaculture system (RAS) deployments, broodstock management innovations, and market expansion efforts. Monitor developments in AQB's vertically integrated operations – from egg incubation to harvest – that reduce environmental impact while enhancing production efficiency.
Bookmark this page for structured access to verified information about AquaBounty's bioscience applications and financial performance. Check regularly for objective updates on operational scaling, biosecurity enhancements, and industry recognition in sustainable protein production.
AquaBounty Technologies (NASDAQ: AQB) has adjourned its 2022 Annual Meeting of Stockholders to May 27, 2022, with no business conducted. At this time, 63% of shares were represented, approving two proposals but rejecting a crucial third proposal to increase authorized shares from 80 million to 150 million. This increase is vital for future capital to sustain operations. The meeting will resume virtually, and stockholders are encouraged to vote by the deadline. For more details, visit the SEC’s website or AquaBounty’s official page.
AquaBounty Technologies (AQB) reported financial results for Q1 2022, highlighting a 133 tons harvest of genetically engineered Atlantic salmon, up 46% from the previous quarter. Product revenue rose to $963,000 from $74,000 year-over-year. Despite these gains, the company posted a net loss of $5.1 million, compared to $4.2 million in Q1 2021. The company is advancing its Pioneer, Ohio farm project, with pre-construction activities underway and a goal to start stocking salmon eggs by late 2023. Financing plans include issuing up to $300 million in bonds.
AquaBounty has officially commenced construction of its first 10,000 metric ton Atlantic salmon farm in Pioneer, Ohio, with a projected cost of $290 million to $320 million. This facility aims to enhance productivity in aquaculture and generate over 100 new jobs in the region. Expected to start commercial stocking by late 2023, the farm's Recirculating Aquaculture Systems (RAS) technology is designed to provide sustainable salmon farming, addressing food insecurity while reducing environmental impact.
AquaBounty Technologies, Inc. (Nasdaq: AQB) reported its financial results for Q4 and full year 2021, highlighting commercial scale harvests of genetically engineered Atlantic salmon.
In Q4, the company harvested 91 tons, generating $340,900 in revenue from 101,700 pounds sold. Total revenue for 2021 reached $1.17 million, a significant increase from $128,000 in 2020.
Operating expenses rose to $23.3 million, with a net loss of $22.3 million. The company holds $191.2 million in cash equivalents, enhanced by a public offering of common stock.
AquaBounty Technologies (Nasdaq: AQB) has commenced critical pre-construction activities for its 10,000 Metric Ton salmon farm in Pioneer, Ohio. Key milestones include setting surveyor benchmarks, constructing roadways, and preparing on-site energy infrastructure, with plans to begin construction following the spring thaw. The company is addressing potential supply chain challenges proactively by securing essential technology items. An official groundbreaking ceremony is forthcoming. AquaBounty aims to enhance aquaculture productivity while ensuring sustainable seafood production.
AquaBounty Technologies (AQB) reported significant advancements in 2021 towards its goal of sustainable salmon farming. The company initiated commercial production of its genetically engineered Atlantic salmon in Indiana and Prince Edward Island, fulfilling orders from seafood distributors. Plans for a new 10,000 metric ton facility in Ohio are underway, with an estimated cost of $290-$320 million, supported by bond financing. AquaBounty's robust balance sheet includes nearly $200 million in cash, positioning the company for growth amid rising demand for its products.
AquaBounty Technologies (NASDAQ: AQB) will participate in the H.C. Wainwright BioConnect Conference from January 10-13, 2022. The CEO, Sylvia Wulf, will present virtually on January 10, with the recorded presentation available after 7:00 a.m. ET. This presentation will remain accessible until April 10, 2022. AquaBounty is a leader in sustainable aquaculture, providing fresh Atlantic salmon through land-based farms designed to minimize environmental impact and disease risks. For further details, visit www.aquabounty.com.
AquaBounty Technologies announced the pricing of a public secondary offering of 11,200,000 shares at $2.10 each, with an option for underwriters to purchase an additional 1,680,000 shares. The selling stockholders are affiliated with Third Security, and AquaBounty will not receive proceeds from this offering. The offering is expected to close around November 23, 2021, subject to customary conditions. Oppenheimer & Co. Inc. and Lake Street Capital Markets are managing the offering.
AquaBounty Technologies, Inc. (AQB) announced a proposed underwritten public offering of 11,200,000 shares of common stock by certain selling stockholders affiliated with Third Security. An additional 1,680,000 shares may be purchased by underwriters. AquaBounty will not receive any proceeds from this offering, as the selling stockholders will bear all associated costs. The offering is subject to market conditions, and details are available in a prospectus supplement filed with the SEC.
AquaBounty Technologies reported its financial results for Q3 and the first nine months of 2021. The company harvested 84 tons of genetically engineered (GE) salmon, generating $402,000 in revenue. Year-to-date revenue reached $757,000, significantly up from $77,000 year-over-year. Operating expenses rose to $16.8 million, leading to a net loss of $16.3 million. AquaBounty is progressing on the construction of its Ohio farm, with estimated costs between $290-$320 million, and has initiated bond placement efforts to finance this project. Cash reserves stood at $197.8 million as of September 30, 2021.
